Dupilumab in Adults with Moderate-To-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal-Immunosuppressants: Analysis of Four Phase 3 Trials
Article full text
The above video and graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.